[Pell Bio-Medical] Announcement of Change in Head of R&D
NQ Score
4/100
N1 Content Completeness
2
AI Summary (NQ-processed)
Pell Bio-Medical announced that Deputy Head of R&D Lin Wei-Chi will resign for personal career planning, effective May 20, 2026. The role of Head of R&D will be temporarily assumed by Lin Ren-Jie, the current Director of the R&D Department.